Related Experiment Video
Updated: Aug 11, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation
1Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts, USA. frank-mckeon@hms.harvard.edu
Abstract:
Recent findings from mouse models of BRCA2 genetic lesions have provided intriguing insights and important questions concerning modes of tumor development in familial breast and ovarian cancers. Fibroblasts from mice homozygous for the BRCA2Tr allele grow poorly and display an array of chromosomal abnormalities that are consistent with a role for BRCA2 in DNA repair. This growth defect can be overcome and cellular transformation promoted by the expression of defective, dominant negative alleles of p53 and of the mitotic checkpoint gene Bub1, both of which are known to induce chromosome instability. These findings are mirrored in the genetic lesions sustained in tumors found in the rare BRCA2Tr/Trmice that survive to adulthood, which include defects in p53 as well as the mitotic checkpoint proteins Bub1 and Mad3L. Together, these data hint that tumors in these mice evolve from an unusually intense selective pressure to remove DNA damage checkpoints, which in turn might be facilitated by chromosomal abolition of mitotic checkpoints and the consequent increase in shuffling of genetic information. How these genetic lesions co-operate to yield transformed cells and how these data relate to BRCA1 and BRCA2 defects in the human population are important questions raised by this work.
Insights
Mouse models reveal BRCA2
Area of Science:
- Genetics
- Cancer Biology
- Molecular Oncology
Background:
- BRCA2 is implicated in DNA repair and tumor suppression.
- Defects in BRCA2 are linked to familial breast and ovarian cancers.
- Understanding BRCA2's role in tumorigenesis is crucial.
Purpose of the Study:
- To investigate the role of BRCA2 genetic lesions in tumor development.
- To explore the mechanisms driving tumor formation in BRCA2-deficient models.
- To identify genetic alterations cooperating with BRCA2 loss.
Main Methods:
- Analysis of mouse models with BRCA2 genetic lesions (BRCA2Tr allele).
- Assessment of fibroblast growth, chromosomal abnormalities, and cellular transformation.
- Examination of genetic lesions in tumors from BRCA2Tr/Tr mice.
Main Results:
- BRCA2-deficient fibroblasts exhibit poor growth and chromosomal instability.
- Expression of dominant-negative p53 and Bub1 overcomes growth defects and promotes transformation.
- Tumors in BRCA2-deficient mice show defects in p53 and mitotic checkpoint proteins (Bub1, Mad3L).
Conclusions:
- Tumor evolution in BRCA2-deficient mice involves intense selective pressure to disable DNA damage checkpoints.
- Mitotic checkpoint abrogation and increased genetic information shuffling may facilitate tumor development.
- Further research is needed to understand the interplay of these genetic lesions and their relevance to human BRCA1/BRCA2-related cancers.
Related Concept Videos
Mismatch Repair
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
DNA Damage Can Stall the Cell Cycle

